The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) has become a top destination for cancer treatment in the Gulf. It attracts patients from across the region while continuing to serve Qatar’s local population with world-class care.
Equipped with cutting-edge technology, personalized treatment plans, and a highly skilled multidisciplinary team, NCCCR remains a leader in oncology services. Medical Director and CEO Dr. Mohamed Salem Al-Hassan emphasized the hospital’s growing reputation: “NCCCR is recognized regionally for its exceptional quality of care and innovative treatments. Patients choose us not only for our advanced therapies and state-of-the-art facilities. They also choose us for our holistic, patient-centered approach.”
In 2024, NCCCR treated 508 international patients, reinforcing its position as a preferred choice for cancer care in the GCC. Dr. Al-Hassan highlighted the hospital’s advanced capabilities, including robotic-assisted surgery, precision medicine, and breakthrough hormone and immunotherapies. “HMC is at the forefront of cancer care, offering treatments often unavailable elsewhere in the region. While we welcome international patients seeking specialized care, our primary focus remains on providing Qatar’s residents with the highest standard of treatment. This eliminates the need to travel abroad.”
NCCCR offers a full spectrum of cancer services, including Bone Marrow Transplants, advanced Radiation Oncology with TrueBeam, ETHOS, and CyberKnife technologies, and genetic counseling for hereditary cancer risk assessment. The center also prioritizes mental health, providing psychotherapy support throughout the treatment journey.
As a regional leader, NCCCR remains committed to advancing cancer care through continuous innovation, groundbreaking research, and enhanced treatment protocols. By integrating cutting-edge technology with compassionate care, the center ensures that both local and international patients receive the highest-quality cancer treatment available in the region.
